Clinical trials referral resource: Current clinical trials of epothilone B analog (BMS-247550)

被引：0
|
作者：
Colevas, AD [1 ]
West, PJ [1 ]
Cheson, BD [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
来源：
ONCOLOGY-NEW YORK | 2001年 / 15卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1168 / +
页数：5
相关论文
共 50 条
  • [41] A Phase 2 Study of Epothilone B Analog BMS-247550 (NSC 710428) in Patients With Relapsed Aggressive Non-Hodgkin Lymphomas
    Churpek, Jane E.
    Pro, Barbara
    van Besien, Koen
    Kline, Justin
    Conner, Kathy
    Wade, James L., III
    Hagemeister, Fredrick
    Karrison, Theodore
    Smith, Sonali M.
    CANCER, 2013, 119 (09) : 1683 - 1689
  • [42] Epothilone B analog (BMS-247550) at the recommended phase II dose (RPTD) in patients (pts) with gynecologic (gyn) and breast cancers.
    Chen, T
    Molina, A
    Moore, S
    Goel, S
    Desai, K
    Hamilton, A
    Griffin, T
    Colevas, AD
    Mani, S
    Muggia, F
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 155S - 155S
  • [43] Clinical trials referral resource - Tumor vaccine trials
    不详
    ONCOLOGY-NEW YORK, 1998, 12 (05): : 684 - +
  • [44] Current clinical trials of BAY 43-9006, Part 2 Clinical trials - Referral resource
    Wright, John J.
    Zerivitz, Ken
    Gravell, Amy
    ONCOLOGY-NEW YORK, 2005, 19 (06): : 722 - +
  • [45] Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy
    Roche, Henri
    Yelle, Louise
    Cognetti, Francesco
    Mauriac, Louis
    Bunnell, Craig
    Sparano, Joseph
    Kerbrat, Pierre
    Delord, Jean-Pierre
    Vahdat, Linda
    Peck, Ronald
    Lebwohl, David
    Ezzeddine, Rana
    Cure, Herve
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (23) : 3415 - 3420
  • [46] Phase I clinical and pharmacokinetic study of 3-weekly, 3-h infusion of ixabepilone (BMS-247550), an epothilone B analog, in Japanese patients with refractory solid tumors
    Toshio Shimizu
    Noboru Yamamoto
    Yasuhide Yamada
    Yasuhito Fujisaka
    Kazuhiko Yamada
    Yutaka Fujiwara
    Kyoko Takayama
    Takuto Tokudome
    Judith Klimovsky
    Tomohide Tamura
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 751 - 758
  • [47] Phase I clinical and pharmacology study of the novel epothilone BMS-247550 given weekly in patients with advanced solid tumors.
    Awada, A
    Burris, H
    De Valeriola, D
    Hendlisz, A
    Huart, A
    Gil, T
    Jones, S
    Martin, C
    Crabeels, D
    Litwin, V
    Damle, B
    Moerman, C
    Piccart, M
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3810S - 3810S
  • [48] Phase I clinical and pharmacokinetic study of 3-weekly, 3-h infusion of ixabepilone (BMS-247550), an epothilone B analog, in Japanese patients with refractory solid tumors
    Shimizu, Toshio
    Yamamoto, Noboru
    Yamada, Yasuhide
    Fujisaka, Yasuhito
    Yamada, Kazuhiko
    Fujiwara, Yutaka
    Takayama, Kyoko
    Tokudome, Takuto
    Klimovsky, Judith
    Tamura, Tomohide
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (05) : 751 - 758
  • [49] Phase I and pharmacokinetic (PK) study of the epothilone-B analogue BMS-247550 by a continuous weekly schedule.
    de Bono, JS
    Hao, D
    Hammond, LA
    Tolcher, AW
    Berg, K
    Bass, A
    Mays, T
    Smith, L
    Drengler, R
    Rowinsky, EK
    BRITISH JOURNAL OF CANCER, 2002, 86 : S110 - S111
  • [50] Phase 2 trial of epothilone B analog BMS-247550 (ixabepilone) in advanced carcinoma of the Urothelium (E3800) - A trial of the Eastern Cooperative Oncology Group
    Dreicer, Robert
    Li, Shuli
    Manola, Judith
    Haas, Naomi B.
    Roth, Bruce J.
    Wilding, George
    CANCER, 2007, 110 (04) : 759 - 763
12345